ZBH · S&P 500 Analyzer

Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.

SMA 20 / 50 / 200

89.87 / 87.48 / 91.20

Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.

MACD / Signal

0.59 / 0.85

MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E

23.7

Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.

Market Cap

17.67B

Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.

Div Yield

1.07%

Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.

52-Week Range

79.12 – 108.29

52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Key Statistics

Enterprise Value

24.79B

Market cap plus total debt minus cash — what it would cost, in theory, to buy the whole company outright and pay off its debt.

Beta

0.46

How much this stock tends to move relative to the overall market. 1.0 = moves with the market; above 1.0 = more volatile; below 1.0 = less volatile.

EPS (TTM)

$3.86

Earnings per share over the trailing twelve months — net profit divided by shares outstanding.

Forward P/E

10.1

Price divided by analysts' expected earnings per share for the next 12 months, instead of the last 12.

Price/Book

1.39

Price divided by book value (assets minus liabilities) per share. A rough gauge of how much investors are paying above the company's accounting net worth.

Shares Outstanding

193.46M

Total number of shares currently held by all shareholders.

Avg Volume

2.45M

Average number of shares traded per day over the last 3 months.

Trend Analysis

Zimmer Biomet Holdings, Inc. is trading at $91.35, +1.90% versus the previous close. The price sits roughly in the middle of its 52-week range.

RSI is in a neutral range — no strong overbought/oversold signal.

The 50-day average is below the 200-day average ("death cross" territory) — a commonly watched bearish signal.

MACD is below its signal line — momentum currently leans negative.

Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

ZBH Zimmer Biomet Holdings, Inc.

2-Week Technical Outlook

Favorites

All Stocks

Compare

Technical Indicators

Fundamentals

Key Statistics

Trend Analysis

Latest News

☆ ZBH Zimmer Biomet Holdings, Inc.

2-Week Technical Outlook

Favorites

All Stocks

Compare

Technical Indicators

Fundamentals

Key Statistics

Trend Analysis

Latest News

ZBH Zimmer Biomet Holdings, Inc.